Check Out What Whales Are Doing With NVO


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Financial giants have made a conspicuous bearish move on Novo Nordisk. Our analysis of options history for Novo Nordisk (NYSE:NVO) revealed 15 unusual trades.

Delving into the details, we found 46% of traders were bullish, while 53% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $289,840, and 11 were calls, valued at $696,758.

Projected Price Targets

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $100.0 to $160.0 for Novo Nordisk over the last 3 months.

Insights into Volume & Open Interest

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for Novo Nordisk's options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Novo Nordisk's whale activity within a strike price range from $100.0 to $160.0 in the last 30 days.

Novo Nordisk Option Volume And Open Interest Over Last 30 Days

Significant Options Trades Detected:

SymbolPUT/CALLTrade TypeSentimentExp. DateAskBidPriceStrike PriceTotal Trade PriceOpen InterestVolume
NVOCALLSWEEPBEARISH07/19/24$15.5$15.0$15.07$115.00$151.0K73980
NVOPUTTRADEBULLISH05/17/24$16.1$15.85$15.85$140.00$137.8K1040
NVOCALLSWEEPBEARISH07/19/24$15.85$15.0$15.05$115.00$105.4K73980
NVOPUTTRADEBEARISH07/19/24$12.3$12.15$12.3$135.00$87.3K1.2K71
NVOCALLTRADEBEARISH09/20/24$8.05$8.0$8.0$135.00$80.0K1.6K131

About Novo Nordisk

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Following our analysis of the options activities associated with Novo Nordisk, we pivot to a closer look at the company's own performance.

Current Position of Novo Nordisk

  • Trading volume stands at 1,730,394, with NVO's price down by -2.2%, positioned at $124.65.
  • RSI indicators show the stock to be may be oversold.
  • Earnings announcement expected in 23 days.

Expert Opinions on Novo Nordisk

A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $160.0.

  • In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $160.
  • In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $160.
  • In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $160.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Novo Nordisk options trades with real-time alerts from Benzinga Pro.


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: OptionsMarketsBZI-UOA